Recombinant multi-species PKN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PKN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the protein kinase C superfamily. This kinase is activated by Rho family of small G proteins and may mediate the Rho-dependent signaling pathway. This kinase can be activated by phospholipids and by limited proteolysis. The 3-phosphoinositide dependent protein kinase-1 (PDPK1/PDK1) is reported to phosphorylate this kinase, which may mediate insulin signals to the actin cytoskeleton. The proteolytic activation of this kinase by caspase-3 or related proteases during apoptosis suggests its role in signal transduction related to apoptosis. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
The Alternative Names of target: DBK,F730027O18Rik,PAK-1,PAK1,PKN,PKN-ALPHA,PKN1,PRK1,PRKCL1,Pkn,Pkn1,Prkcl1,Protease-activated kinase 1 (PAK-1),Protein kinase C-like 1,Protein kinase C-like PKN,Protein kinase PKN-alpha,Protein-kinase C-related kinase 1,Serine-threonine protein kinase N,Serine/threonine-protein kinase N1,Stk3

Target products collectionGo to PKN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T60003-Ag-1/ GM-Tg-hg-T60003-Ag-2 Human PKN1 protein Human
GM-Tg-rg-T60003-Ag-1/ GM-Tg-rg-T60003-Ag-2 Rat PKN1 protein Rat
GM-Tg-mg-T60003-Ag-1/ GM-Tg-mg-T60003-Ag-2 Mouse PKN1 protein Mouse
GM-Tg-cynog-T60003-Ag-1/ GM-Tg-cynog-T60003-Ag-2 Cynomolgus/Rhesus macaque PKN1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T60003-Ag-1/ GM-Tg-felg-T60003-Ag-2 Feline PKN1 protein Feline
GM-Tg-cang-T60003-Ag-1/ GM-Tg-cang-T60003-Ag-2 Canine PKN1 protein Canine
GM-Tg-bovg-T60003-Ag-1/ GM-Tg-bovg-T60003-Ag-2 Bovine PKN1 protein Bovine
GM-Tg-equg-T60003-Ag-1/ GM-Tg-equg-T60003-Ag-2 Equine PKN1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T60003-Ag-1/ GM-Tg-hg-T60003-Ag-2; GM-Tg-rg-T60003-Ag-1/ GM-Tg-rg-T60003-Ag-2;
GM-Tg-mg-T60003-Ag-1/ GM-Tg-mg-T60003-Ag-2; GM-Tg-cynog-T60003-Ag-1/ GM-Tg-cynog-T60003-Ag-2;
GM-Tg-felg-T60003-Ag-1/ GM-Tg-felg-T60003-Ag-2; GM-Tg-cang-T60003-Ag-1/ GM-Tg-cang-T60003-Ag-2;
GM-Tg-bovg-T60003-Ag-1/ GM-Tg-bovg-T60003-Ag-2; GM-Tg-equg-T60003-Ag-1/ GM-Tg-equg-T60003-Ag-2
Products Name PKN1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PKN1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PKN1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.